A new study shows that the over-the-counter (OTC) versions of Nexium (esomeprazole) and Prevacid (Aciphex) are also working for heartburn and acid reflux symptoms.
The research was presented at the 2016 American Heart Association Scientific Sessions and the 2016 British Association for the Study of Heart Disease (BASHD) Conference, which took place at the New York Medical School in September 2016.
According to the study, the over-the-counter (OTC) versions of Nexium (esomeprazole) and Prevacid (Aciphex) are also working for heartburn and acid reflux symptoms.
In addition to the brand name for Nexium, a brand name for Prevacid, there are other brand names for other medications such as omeprazole and esomeprazole. Both of these brands are prescription drugs, and they both work in the same way.
Nexium is indicated for the treatment of frequent heartburn. Prevacid is indicated for the treatment of acid reflux and heartburn.
Esomeprazole is indicated for the treatment of gastroesophageal reflux disease (GERD). It is also indicated for the treatment of gastric and duodenal ulcers.
Aciphex is indicated for the treatment of H. pylori infection. It is also indicated for the treatment of peptic ulcers, which is an infection that causes stomach pain and ulcers.
Both medications are used to treat high-risk conditions.
The study, published in theJournal of Clinical Gastroenterology., found that the over-the-counter (OTC) versions of both omeprazole and esomeprazole had fewer side effects than the brand-name versions.
The study was funded by A/Byers Medical Information. The authors report no other conflicts of interest.
Image: © CC BY-NC-ND 2.0In the study, researchers found that over-the-counter (OTC) versions of both omeprazole and esomeprazole had fewer side effects than the brand-name versions. The medication also has other active ingredients, which include magnesium, aluminum, and calcium.
The studies were published inJAMA Internal Medicine.
In addition to omeprazole, the study also found that the over-the-counter (OTC) versions of both omeprazole and esomeprazole had fewer side effects than the brand-name versions.
The study was published in theBritish Medical Journal
The study was supported by A/Byers Medical Information.
In addition to omeprazole and esomeprazole, the study also found that the over-the-counter (OTC) versions of both omeprazole and esomeprazole have fewer side effects than the brand-name versions.
In general, the findings suggest that taking the prescription-strength version of the medication can help reduce the frequency of side effects. They also show that the brand-name versions of both omeprazole and esomeprazole may be more effective than the prescription-strength versions.
SOURCE:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058280/
References:1. Amalio, D., Rizzo, C., Mazzagalli, R., Gagnini, A., Guglione, L., et al. (2017) The safety and efficacy of proton pump inhibitor (PPI) proton pump inhibitors in adults with gastroesophageal reflux disease. JAMA Gastroenterol. 154(1):e10075. doi: 10.1001/j.1442-6381.2015.113020. PMC396713
Open Access Neuroscience News:Access | News | Updates | Cancelovica | News© Copyright 2016 The AstraZeneca Company, Inc.
Nexium Control provides effective relief from frequent heartburn, acid reflux, and gastroesophageal reflux disease (GERD) in adults. Nexium Control helps you to avoid frequent heartburn and acid reflux.
Nexium Control contains the active ingredient esomeprazole, which belongs to a class of drugs called proton pump inhibitors (PPIs). It works by reducing the amount of stomach acid produced by the stomach. Lowering your acid makes your body more acid-helping bacteria lives in your stomach.
Esomeprazole Control is used for controlling frequent heartburn and acid reflux. It helps your body eliminate acid from your stomach and helps you to avoid frequent heartburn and acid reflux. Nexium Control may be used for other purposes the same way as other PPIs and not be confused with Nexium.
Nexium Control contains esomeprazole, the active ingredient, which belongs to a class of drugs called proton pump inhibitors (PPIs). Nexium Control helps your body eliminate acid from your stomach and uses it to treat reflux, a common condition in heartburn that occurs due to frequent heartburn.
Esomeprazole Control blocks an enzyme in the stomach that produces acid. When a person is in an acid-related state they may develop acid reflux disease (ARD) or GERD. Nexium Control helps to reduce the amount of acid produced by the stomach in a person by blocking the enzymes in the gut that produce gastric acid.
Take one tablet once daily with each main meal you eat. Nexium Control may take 1 to 2 days for full effect. If you need to take Nexium Control for more than 2 days in a row, contact your doctor.
Get emergency medical help if you have any of these signs or symptoms of an allergic reaction:
Contact your doctor immediately if you have any of these symptoms of an allergic reaction:
Before you take Nexium Control, tell your health care provider if you have any medical conditions, especially if any of the following apply to you:
Your health care provider may need to change your dose or monitor you carefully for side effects. If you have any questions about this medicine, ask your doctor or pharmacist.
Keep all medicines out of the reach of children.
If you are allergic to esomeprazole or any other ingredient in esomeprazole Control, do not take esomeprazole Control, or any other drug, without asking your doctor.
If you are allergic to esomeprazole or any other ingredient in esomeprazole Control, or any other drug, take special care with your medication. Ask your doctor about this if you are not sure whether any of your medications contain esomeprazole or any other ingredients.
Do not stop taking Nexium Control without first checking with your doctor.
Nexium 24HR tablets provide lasting relief from the symptoms of heartburn, acid regurgitation and other symptoms associated with gastroesophageal reflux.
Nexium 24HR tablets are given as one tablet at meals and at least 30 minutes before any other treatment methods.
We only sell the best substitute from top brands for ourall best products.
Nexium 24HR Tablets are a proven treatment for heartburn, acid regurgitation and other symptoms associated with gastroesophageal reflux.
Take this medication as prescribed by your GP. Take this product on an empty stomach, at least 30 minutes before any other treatments, and for the full period of your treatment unless otherwise directed by your doctor.Please note:This product is to be stored at room temperature.
Do not chew, crush or open the capsule - swallow whole. Do not chew the tablet or crush it unless your doctor tells you to do so. Do not chew the tablet or crush it unless instructed to do so.
Do not take Nexium 24HR if:
Information for women and children below 18 years:
Information for children and adolescents:
Information for adults:
AstraZeneca's biggest pharmaceutical company has agreed to pay $1 billion for selling its drugs to New York, New Jersey and Pennsylvania, with the proceeds benefiting the firm's shareholders.
The agreement, announced Monday, comes as the world's largest pharmaceutical company has faced one of the largest price spikes in more than a century.
Nexium, the blockbuster heartburn drug used to treat gastroesophageal reflux disease, had a $1 billion price increase in the third quarter compared with the same period in 2011.
AstraZeneca will be required to pay $1.7 billion to settle the lawsuit over the drug's price increase. The settlement will allow AstraZeneca to bring in the $1 billion in cash it has agreed to pay to the firm for its share of the proceeds from the agreement.
AstraZeneca will pay a $4 billion settlement, the largest in its history, to help pay for the settlement and the $1.7 billion in cash it will receive from the firm in exchange for paying the firm a share of the proceeds from the settlement.
The settlement will also help pay for the $1.5 billion in cash that AstraZeneca will receive from the settlement. The settlement will cover the full cost of the drug, including future sales. The settlement will also provide AstraZeneca with a share of the $3 billion in cash that the firm will receive from the settlement and will help cover the $4 billion in future sales.
AstraZeneca is one of the largest drugmakers in the world, with more than 100,000 employees in more than 10 countries. It is one of the world's largest pharmaceutical companies. It is the largest pharmaceutical company in the world and has more than 5,000 employees in more than 100 countries.
It will not be the first time that AstraZeneca has agreed to pay for sales and marketing of its drugs.
In 2007, AstraZeneca agreed to pay $1.2 billion to resolve the issue of a $4 billion settlement with the drug maker, the New Jersey company.
This settlement is in response to the drug maker's recent decision to raise its price to $2.5 billion.
In April, AstraZeneca agreed to pay $3.4 billion to settle a $2.5 billion lawsuit that alleged the company failed to disclose the value of its drugs. That case is still pending.
AstraZeneca will pay a $4 billion settlement to New Jersey and Pennsylvania. It will also pay $4 billion to settle a $3 billion lawsuit that claimed the company improperly sold its drugs to the state.
AstraZeneca will not be the first drugmaker to agree to pay for its drug sales. AstraZeneca's first-line care for its heartburn and asthma patients is AstraZeneca's first-line care for patients with other chronic illnesses.
The New York-based company has been in the spotlight in recent years due to the huge price increase for its drugs. The company will pay a $4 billion settlement to settle the lawsuit, which claims that AstraZeneca failed to disclose its drug price increase.
The New York lawsuit, filed in federal court last month, alleges that AstraZeneca failed to adequately disclose the price of its heartburn and asthma drugs. The suit claims that AstraZeneca failed to report the high-dose therapy for asthma from AstraZeneca's sales and marketing of the drugs.
In a statement to Reuters, AstraZeneca said: "We are pleased that AstraZeneca has agreed to pay the full cost of our drugs, including sales and marketing of our new drugs, through our agreement with the New Jersey and Pennsylvania firm."
AstraZeneca's statement also stated: "In addition to the $1 billion settlement, we will pay the full cost of our existing patents for a number of generic drugs, including Nexium, which is a brand-name product used to treat the symptoms of GERD, a common heartburn."
In the New York lawsuit, the company agreed to pay $1 billion to settle a $4 billion lawsuit over the drug's price increase.
AstraZeneca will pay $4 billion to New Jersey and Pennsylvania for its drug, AstraZeneca has said.
The settlement will also help pay for the $1.5 billion in cash that AstraZeneca will receive from the settlement and will help cover the $4 billion in future sales.
The New York-based drugmaker will pay a $4 billion settlement to New Jersey and Pennsylvania, which has a $1.
Stade de France Pharmacy